相关实验视频

Updated: Sep 13, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

通过恢复T细胞受体信号传递来解决状细胞癌

Peiying Ye¹, Jenna R E Bergerson², Isaac Brownell³

¹Laboratory of Immunoregulation and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD.

The New England journal of medicine

|July 31, 2025

概括

这项研究揭示了β-人类乳头瘤病毒 (β-HPV) 直接导致T细胞受体 (TCR) 信号缺陷的个体患皮肤癌. 恢复TCR信号解决了与HPV相关的疾病,突出了β-HPV.

科学领域:

在瘤学瘤学.
病毒学病毒学
免疫学免疫学免疫学

背景情况:

皮肤状细胞癌 (SCC) 与紫外线辐射有关,而β-人类乳头瘤病毒 (β-HPV) 被认为是轻微的贡献者.
在T细胞受体 (TCR) 信号的缺陷损害了适应性免疫力,可能影响HPV相关的瘤发生.

研究的目的:

为了研究β-HPV在皮肤致癌中的作用,在患有遗传T细胞信号缺陷的患者中.
为了确定恢复T细胞功能是否可以解决与HPV相关的疾病.

主要方法:

一位患有侵入性皮肤SCC,β-HPV19整合和ZAP70缺乏症的患者的案例研究.
对TCR信号传导通路的分析.
通过异性造血细胞移植进行治疗.

主要成果:

该患者出现了复发性,不可切除的皮肤SCC和其他与HPV相关的疾病.
在SCC中检测到β-HPV19的基因组整合.
成功的全原造血细胞移植恢复了TCR信号,并导致所有与HPV相关的疾病完全消失.

结论:

β-HPV在免疫功能低下的个体,具有缺陷的适应性T细胞反应的皮肤致癌过程中发挥着直接作用.
恢复T细胞受体信号传递对于控制β-HPV驱动疾病至关重要.
这一案子挑战了 β-HPV 作为皮肤SCC中不可缺少的辅助因子的观点.

更多相关视频

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...